scispace - formally typeset
C

Christopher J. Hetherington

Researcher at Harvard University

Publications -  32
Citations -  5443

Christopher J. Hetherington is an academic researcher from Harvard University. The author has contributed to research in topics: Transcription factor & Regulation of gene expression. The author has an hindex of 27, co-authored 32 publications receiving 5268 citations. Previous affiliations of Christopher J. Hetherington include Boston University & Beth Israel Deaconess Medical Center.

Papers
More filters
Journal ArticleDOI

Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein α-deficient mice

TL;DR: A model by which transcription factors can direct the differentiation of multipotential precursors through activation of expression of a specific growth factor receptor, allowing proliferation and differentiation in response to a specific extracellular signal is suggested.
Journal ArticleDOI

The macrophage transcription factor PU.1 directs tissue-specific expression of the macrophage colony-stimulating factor receptor.

TL;DR: In this paper, the authors investigated whether PU.1 binds and activates the macrophage colony-stimulating factor (M-CSF) receptor promoter in a tissue-specific fashion from two distinct promoters in monocytes and the placenta.
Journal ArticleDOI

CCAAT enhancer-binding protein (C/EBP) and AML1 (CBF alpha2) synergistically activate the macrophage colony-stimulating factor receptor promoter.

TL;DR: It is demonstrated that C/EBP and AML1 are important factors for regulating a critical hematopoietic growth factor receptor, the M-CSF receptor, suggesting a mechanism of how the AML 1 fusion protein could contribute to acute myeloid leukemia.
Journal ArticleDOI

Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene.

TL;DR: Mice heterozygous for an AML1–ETO allele (AML1—ETO/+) die in midgestation from haemorrhaging in the central nervous system and exhibit a severe block in fetal liver haematopoiesis, indicating that AML-ETO blocks normal AML 1 function.